BP

Nystatin

Proprietary

Nystan^® (E.R. Squibb and Sons Ltd)
Nystaform^® cream (Typharm Ltd)

Group

Antifungal

Uses/indications

Candidiasis in the mouth, oesophagus or intestinal tract

Type of drug

POM

Presentation

Oral suspension (yellow), cream (light yellow)

Dosage

Adult: oral – 500 000 units q.d.s. for 7 days, i.e. 5 mL suspension (contains sugar); cream –100 000 units/g 2–3 times per day to affected skin
Paediatric: oral – 100 000 units q.d.s. for 7 days, i.e. 1 mL suspension (contains sugar)

Route of admin

Oral

Contraindications

Hypersensitivity to constituents

Side effects

Nausea, vomiting, hypersensitivity

Interactions

No data available

Pharmacodynamic properties

Antifungal that is not absorbed by the gastrointestinal tract, skin or vagina, and that inhibits growth of microbes, mostly yeasts and yeast-like fungi, e.g. Candida albicans

Fetal risk

No reports of complications after administration in pregnancy